Description
Research Areas
- Quad-pathway metabolic receptor research
- Maximum appetite suppression signaling
- Advanced obesity and metabolic syndrome models
$279.00
Ultra-advanced combination of triple-agonist Retatrutide with amylin analog Cagrilintide. Targets four metabolic receptor pathways simultaneously — GIP, GLP-1, glucagon, and amylin.
Phorm Labs
Research Areas
| Weight | .20 lbs |
|---|---|
| Dimensions | 7 × 4 × 3 in |
| Please Select | 10mg |
Reviews
There are no reviews yet.